Latest News and Press Releases

Medicovestor and Sanyou team up to develop first-in-class chemoimmunotherapy ADCs, combining AI antibody tech with novel dual-targeting platforms.

Expanded collaboration leverages complementary expertise to unlock next-generation oncology therapeuticsFocus on breakthrough ADC payloads and immuno-oncology candidates with out-licensing potential ...

New York, USA, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Antibody-Drug Conjugates Market to Witness Rapid Growth Across 7MM During the Study Period (2020–2034) as New Innovations Drive Therapy Advancements...

Nashville, TN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”) has launched Ignite Proteomics LLC (“Ignite”), its new subsidiary dedicated to...

Hummingbird Bioscience Licenses Novel Antibodies to Immunome

Gain comprehensive insights into the ADC market with the Alira Health 2024 Global Antibody-Drug Conjugates Report's in-depth analysis.

Hummingbird Bioscience today announced a poster presentation on HMBD-802, a dual-payload ADC, at the 36th EORTC-NCI-AACR symposium.

MAINZ, Deutschland, 05. September 2024 – BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf dem diesjährigen Kongress der European Society for Molecular Oncology („ESMO“), der vom...

MAINZ, Germany, September 05, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the...

Hummingbird Bioscience Announces Key Leadership Appointments • Kon Yew Kwek appointed Chief Medical Officer • Lisa Ooi appointed Chief Operating Officer